Our goal at Chronos is not simply to push patients to the highest dose possible
In in vitro models (INS-1, MIN6, TC-6 lines, SH-SY5Y neural cells, HEK293 transfected with GLP-1R) studies of receptor affinity, activation kinetics and the effect on the expression of metabolic-response genes (PDX-1, GLUT2, glucokinase) are carried out
It's crucial to approach such combinations with an understanding of their distinct pathways and the current limitations of published data
Im always happy to help guide the conversation.
Proactive Management Understanding these risk factors allows you to take proactive steps in managing and preventing cramps while on semaglutide
In practice, that list is largely the GLP-1 weight-loss class and a small number of FDA-approved agents